Please note, this OEL/ADE monograph also applies to fusidic hydrochloride (CAS RN 751-94-0). Fusidic acid is an antibiotic used in both human and veterinary medicine to treat systemic infections and infections on the skin and in the eye including, but not limited to cutaneous infections, pneumonia, infection in the bone, wound infections, infection in the heart, and super infected cystic fibrosis. Fusidic acid inhibits the growth of bacteria by inhibiting the translocation of transfer-RNA in the ribosome, which is necessary for protein synthesis.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), and to obtain the following information:
To order an OEL/ADE monograph for Fusidic Acid, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’s OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.